TikTok celebrates berberine as a plant-based weight-loss injection. We examine the current state of studies, the EFSA safety assessment, and whether berberine is even allowed to be sold in Germany.
To legal status →No, berberine is not a natural alternative to weight-loss injections containing active ingredients like semaglutide, and it cannot be advertised as such in Germany. The consumer protection agency (Verbraucherzentrale) clarifies that there is no compelling human evidence for the claimed mechanism of action—an increase in the gut hormone GLP-1. Additionally, there is a point that most social media posts omit: pure berberine is currently not permitted for sale as a dietary supplement in the EU, and as of January 2026, the EFSA is further investigating serious safety concerns. In this article, we show you what a few controlled studies have actually found regarding effects on weight and blood sugar, what risks have been documented, and which alternative is legally sold in Germany and carries an approved health claim.
- Is berberine a natural Ozempic?
- Is berberine even allowed to be sold in Germany?
- What do studies really show on weight and blood sugar?
- Expert Perspectives & Protocol Breakdown
- Berberine compared to GLP-1 medications
- Side effects and risk groups
- Is there a legal, well-supported alternative?
- Frequently Asked Questions
Is berberine a natural Ozempic?
No. Semaglutide, the active ingredient in Ozempic and Wegovy, is a prescription GLP-1 receptor agonist with a pharmacologically proven, very strong appetite-suppressing effect. Berberine is a plant compound for which there are no approved health-related claims, and its alleged GLP-1 effect is not, according to the consumer protection agency, convincingly proven. The US National Center for Complementary and Integrative Health (NCCIH) concludes that there are only very few, predominantly Asian studies on weight loss with berberine, often conducted on individuals who are already ill, and that the overall data is insufficient.
→ Source: Verbraucherzentrale, Klartext Nahrungsergänzung "Berberin zum Abnehmen?", as of 01/29/2026 · NCCIH, Berberine and Weight Loss: What You Need To Know
Advertising claims such as "plant-based Ozempic" or "natural blood sugar regulator" are not permitted for dietary supplements in Germany because dietary supplements are not allowed to have a pharmacological effect; this is reserved for medicinal products.
→ Source: Verbraucherzentrale, Klartext Nahrungsergänzung, as of 01/29/2026
Is berberine even allowed to be sold in Germany?
Pure berberine is currently not permitted for use as an ingredient in dietary supplements in the EU because it is considered a "novel food," and no authorization has been granted to date. An application for authorization of berberine hydrochloride has been pending since 2023, and the EFSA has been reviewing its safety since May 2024. According to the consumer protection agency, the only thing that might be permitted is a barberry fruit extract containing berberine as an ingredient, but not the plant's bark or root (bark), which are classified as medicinal substances with an unfavorable benefit-risk profile.
→ Source: Verbraucherzentrale, Klartext Nahrungsergänzung "Berberin zum Abnehmen?", as of 01/29/2026
On January 29, 2026, the relevant EFSA panel (Nutrition, Novel Foods and Food Allergens) also published a draft of an independent safety assessment on plant preparations containing berberine. The preliminary result: A safe daily dose cannot currently be established, and according to the EFSA, there is compelling evidence of genotoxicity of berberine in in-vitro studies. The public consultation on this matter was extended until July 10, 2026; a final, legally binding assessment is not yet available at the time of this article.
Despite the lack of authorization, numerous highly concentrated berberine products are being offered, especially online. This does not change the legal situation: there is no official pre-market testing for these products; the vendor alone is liable for the safety of their product.
→ Source: Verbraucherzentrale / BVL, as of 01/29/2026
What do studies really show on weight and blood sugar?
Controlled studies find measurable but small effects for berberine, not in the same order of magnitude as GLP-1 medications. A dose-response meta-analysis by Fatahi et al. (2020, Complementary Therapies in Medicine) involving ten randomized controlled trials found a significant reduction in BMI (-0.29 kg/m², p = 0.006) and waist circumference (-2.75 cm, p = 0.01), but no significant change in body weight itself (-0.11 kg, p = 0.79). A second meta-analysis by Asbaghi, Ghanbari, Shekari et al. (2020, Clinical Nutrition ESPEN) involving twelve studies found slightly larger but still moderate effects on body weight (-2.07 kg), and a third, newer meta-analysis by Elahi Vahed et al. (2025, International Journal of Obesity) involving 23 studies found an average of -0.88 kg.
→ Source: Fatahi, Y. et al., The Effect of Berberine Supplementation on Obesity Indices: A Dose-Response Meta-Analysis and Systematic Review of Randomized Controlled Trials, Complementary Therapies in Medicine (2020) · Asbaghi, O., Ghanbari, N., Shekari, M. et al., The Effect of Berberine Supplementation on Obesity Parameters, Inflammation and Liver Function Enzymes, Clinical Nutrition ESPEN (2020) · Elahi Vahed et al., The Effect of Berberine on Obesity Indices: A Systematic Review and Meta-Analysis, International Journal of Obesity (2025)
The data for blood sugar appears somewhat more consistent. An older but frequently cited meta-analysis by Dong et al. (2012) including 14 randomized trials and 1,068 participants found that berberine combined with lifestyle changes lowered blood sugar more than lifestyle changes alone; however, in direct comparison with oral antidiabetics like metformin, berberine did not show significantly better blood sugar control. A newer systematic review by Xie, Su, Wang et al. (2022, Frontiers in Pharmacology) confirms a blood sugar-lowering effect in type 2 diabetes, but classifies the quality of the individual studies as mostly moderate to low.
→ Source: Dong, H. et al., Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis, PMC3478874 (2012) · Xie, W., Su, F., Wang, G. et al., Glucose-Lowering Effect of Berberine on Type 2 Diabetes: A Systematic Review and Meta-Analysis, Frontiers in Pharmacology, DOI 10.3389/fphar.2022.1015045 (2022)
Expert Perspectives & Protocol Breakdown
Fatahi, Asbaghi, Elahi Vahed, and the other meta-analysis teams follow an efficacy approach: they statistically pool existing randomized controlled trials to estimate an average effect size for weight, BMI, or blood sugar. The result is small, partly inconsistent, but measurable effects, ranging between -0.11 kg (not significant) and -2.07 kg depending on the studies included.
In contrast, the EFSA follows a precautionary hazard identification approach in its safety assessment: instead of asking about the average benefit, it examines whether there is any evidence of risk—in this case, compelling in-vitro evidence of genotoxicity. This approach can lead to a warning, even if efficacy research simultaneously shows a positive, albeit small, effect. For consumers, the juxtaposition means: a measured effect and an unresolved safety issue are not mutually exclusive; this is precisely what currently makes berberine a borderline case between "works a little" and "not yet tested enough for safety."
| Meta-analysis | Number of studies | Key result |
|---|---|---|
| Fatahi et al., 2020 | 10 RCTs | BMI -0.29 kg/m², weight n.s. |
| Asbaghi et al., 2020 | 12 RCTs | Weight -2.07 kg |
| Dong et al., 2012 | 14 RCTs, n=1,068 | Blood sugar ↓, no better than metformin |
n.s. = not statistically significant. RCT = randomized controlled trial.
Berberine compared to GLP-1 drugs
The central difference lies in the magnitude of the effect and the regulatory status, not just "natural versus synthetic". GLP-1 drugs are approved, doctor-prescribed medications proven in clinical studies to produce double-digit percentage weight loss. Berberine is a food supplement ingredient currently not eligible for approval in the EU, with small, inconsistent effects seen in a few, mostly short-term studies.
| Criterion | GLP-1 drugs (e.g., Semaglutide) | Berberine (supplement) |
|---|---|---|
| Status | Approved prescription drug | Currently not eligible for approval as a supplement in the EU |
| Mechanism of action | Proven GLP-1 receptor agonism | Claimed GLP-1 effect, not convincingly proven |
| Pre-sale oversight | Drug approval required | No regulatory pre-approval |
| Magnitude of weight effect | Double-digit percentage in clinical trials | Approx. -0.1 to -2 kg in meta-analyses |
Side effects and risk groups
Reported toxic effects of berberine include dizziness, nosebleeds, vomiting, diarrhea, as well as kidney irritation and inflammation; additionally, sensitivity to UV radiation may increase. The French food safety authority ANSES also lists gastrointestinal disorders, hypoglycemia, and drops in blood pressure as potential consequences of berberine-containing supplements.
According to ANSES, children and adolescents, pregnant and breastfeeding women, people with diabetes mellitus, and individuals with liver or heart disease should avoid berberine-containing preparations. Interactions have been documented with sulfonylureas, immunosuppressants, as well as CBD, garlic, ginger, ginkgo, nattokinase, and Panax ginseng, some with a risk of cardiac arrhythmias or reduced blood clotting.
Do not take berberine-containing supplements without prior medical consultation, especially in combination with other medications or supplements. This article does not replace individual medical advice.
Is there a legal, well-supported alternative?
Yes: unlike berberine, chromium is a supplement ingredient approved in the EU with an officially authorized health claim. According to the EU Health Claims Regulation, chromium contributes to normal macronutrient metabolism and supports the maintenance of normal blood sugar levels. This is a much more modest, yet legally backed health claim—not a substitute for a GLP-1 medication, but an honestly communicated, legal option.
→ Source: EU Register of authorized health claims (Chromium)
We explain how apple cider vinegar itself performs scientifically regarding blood sugar and metabolism in detail in our Apple Cider Vinegar Effects Study Check. Those looking for a realistic, holistic approach will find step-by-step instructions without miracle-cure promises in our 30-Day Plan. Our article on the weight-loss injection and nutrient deficiency shows why GLP-1 drugs themselves can lead to nutrient deficiencies.
Frequently Asked Questions
Is berberine a natural Ozempic?
No. The claimed GLP-1 effect of berberine is not convincingly supported according to consumer advocacy centers and the NCCIH, and advertising with this claim is not permitted for food supplements in Germany.
Can berberine be sold as a food supplement in Germany?
Pure berberine is currently not permitted as a supplement ingredient as it is a "novel food" without approval. Additionally, EFSA has been reviewing the safety of berberine-containing plant preparations since January 2026; a final assessment is not yet available.
How much weight do studies show you lose with berberine?
Meta-analyses find effects ranging from about -0.1 kg (not significant) to -2 kg on average, sometimes with stronger reductions in BMI and waist circumference than in body weight itself. This is significantly smaller than the effect of GLP-1 drugs.
What are the side effects of berberine?
Documented side effects include gastrointestinal complaints, dizziness, kidney irritation, increased UV sensitivity, and interactions with several medications and food supplements.
Who should not take berberine?
According to ANSES, children and adolescents, pregnant and breastfeeding women, and people with diabetes or liver/heart disease should avoid berberine-containing products and always seek medical advice if in doubt.
References & Scientific Citations
- Verbraucherzentrale (2026). Klartext Nahrungsergänzung "Berberine for weight loss?", as of Jan 29, 2026
- EFSA NDA Panel (2026). Draft Scientific Opinion on the Safety of Plant Preparations Containing Berberine, Jan 29, 2026
- NCCIH. Berberine and Weight Loss: What You Need To Know
- Fatahi, Y. et al. (2020). The Effect of Berberine Supplementation on Obesity Indices: A Dose-Response Meta-Analysis and Systematic Review of Randomized Controlled Trials, Complementary Therapies in Medicine
- Asbaghi, O., Ghanbari, N., Shekari, M. et al. (2020). The Effect of Berberine Supplementation on Obesity Parameters, Inflammation and Liver Function Enzymes, Clinical Nutrition ESPEN
- Elahi Vahed et al. (2025). The Effect of Berberine on Obesity Indices: A Systematic Review and Meta-Analysis, International Journal of Obesity
- Dong, H. et al. (2012). Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis, PMC3478874
- Xie, W., Su, F., Wang, G. et al. (2022). Glucose-Lowering Effect of Berberine on Type 2 Diabetes: A Systematic Review and Meta-Analysis, Frontiers in Pharmacology, DOI 10.3389/fphar.2022.1015045
- ANSES. Opinion on the Safety of Use of Berberine-Containing Plants in the Composition of Food Supplements
- European Commission. EU Register of authorized health claims (Chromium)
Better to be legal and well-supported than trendy and unclear
Apple cider vinegar gummies with chromium and vitamin B6, authorized health claim, sugar-free and vegan, Made in Germany.
View now →Food supplements are not a substitute for a balanced, varied diet and a healthy lifestyle.
